Encompass Health Corp Files Definitive Proxy Statement

Ticker: EHC · Form: DEF 14A · Filed: Apr 2, 2024 · CIK: 785161

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Encompass Health, Executive Compensation, Shareholder Meeting

TL;DR

<b>Encompass Health Corp has filed its Definitive Proxy Statement for the period ending May 2, 2024.</b>

AI Summary

Encompass Health Corp (EHC) filed a Proxy Statement (DEF 14A) with the SEC on April 2, 2024. Encompass Health Corp filed a Definitive Proxy Statement (DEF 14A) on April 2, 2024. The filing covers the period ending May 2, 2024. The company's principal executive offices are located at 9001 Liberty Parkway, Birmingham, AL 35242. Encompass Health Corp was formerly known as HealthSouth Corp and HealthSouth Rehabilitation Corp. The filing includes data related to stock and option awards for the fiscal years 2020 through 2023.

Why It Matters

For investors and stakeholders tracking Encompass Health Corp, this filing contains several important signals. This DEF 14A filing is crucial for shareholders as it details executive compensation, board nominations, and other matters to be voted on at the annual meeting. Understanding the details of stock and option awards for the past four fiscal years provides insight into the company's incentive structures and potential future dilution.

Risk Assessment

Risk Level: — Encompass Health Corp shows moderate risk based on this filing. The filing is a routine DEF 14A, providing information to shareholders rather than announcing new financial performance or strategic shifts.

Analyst Insight

Shareholders should review the proxy statement to understand executive compensation and vote on matters presented at the upcoming annual meeting.

Key Numbers

Key Players & Entities

FAQ

When did Encompass Health Corp file this DEF 14A?

Encompass Health Corp filed this Proxy Statement (DEF 14A) with the SEC on April 2, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Encompass Health Corp (EHC).

Where can I read the original DEF 14A filing from Encompass Health Corp?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Encompass Health Corp.

What are the key takeaways from Encompass Health Corp's DEF 14A?

Encompass Health Corp filed this DEF 14A on April 2, 2024. Key takeaways: Encompass Health Corp filed a Definitive Proxy Statement (DEF 14A) on April 2, 2024.. The filing covers the period ending May 2, 2024.. The company's principal executive offices are located at 9001 Liberty Parkway, Birmingham, AL 35242..

Is Encompass Health Corp a risky investment based on this filing?

Based on this DEF 14A, Encompass Health Corp presents a moderate-risk profile. The filing is a routine DEF 14A, providing information to shareholders rather than announcing new financial performance or strategic shifts.

What should investors do after reading Encompass Health Corp's DEF 14A?

Shareholders should review the proxy statement to understand executive compensation and vote on matters presented at the upcoming annual meeting. The overall sentiment from this filing is neutral.

How does Encompass Health Corp compare to its industry peers?

Encompass Health Corp operates in the healthcare services sector, specifically focusing on hospitals and rehabilitation services.

Are there regulatory concerns for Encompass Health Corp?

The filing is a DEF 14A, a standard SEC filing required for public companies to solicit proxies from shareholders for annual or special meetings.

Industry Context

Encompass Health Corp operates in the healthcare services sector, specifically focusing on hospitals and rehabilitation services.

Regulatory Implications

The filing is a DEF 14A, a standard SEC filing required for public companies to solicit proxies from shareholders for annual or special meetings.

What Investors Should Do

  1. Review the detailed breakdown of executive compensation and equity awards.
  2. Understand the proposals to be voted on at the shareholder meeting.
  3. Assess any changes in corporate governance practices outlined in the filing.

Year-Over-Year Comparison

This filing is a DEF 14A, which is a routine disclosure. No specific comparison to a prior filing's financial performance is available within this document.

Filing Stats: 4,707 words · 19 min read · ~16 pages · Grade level 15 · Accepted 2024-04-02 15:49:30

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 36 Compensation Discussion and Analysis 36 Executive Summary 36

Executive Compensation Philosophy

Executive Compensation Philosophy 38 Determination of Compensation 40 Elements of Executive Compensation 42 Other Compensation Policies & Practices 49 Summary Compensation Table 52 Grants of Plan-Based Awards During 2023 54 Potential Payments upon Termination of Employment 56 Outstanding Equity Awards at December 31, 2023 58 i Page Options Exercised and Stock Vested in 2023 59 Equity Compensation Plans 59 2004 Amended and Restated Director Incentive Plan 59 2008 Equity Incentive Plan 60 2016 Omnibus Performance Incentive Plan 60 Deferred Compensation 61 Retirement Investment Plans 61 Nonqualified Deferred Compensation Plan 61 CEO Pay Ratio 62 Pay vs. Performance 62 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 66 Review and Approval of Transactions with Related Persons 66 Transactions with Related Persons 66

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 67 EXECUTIVE OFFICERS 69 GENERAL INFORMATION 71 APPENDIX A - NOTE REGARDING PRESENTATION OF NON-GAAP FINANCIAL MEASURES A- 1 NOTE TO READERS As used in this report, the terms "Encompass Health," "we," "us," "our," and the "Company" refer to Encompass Health Corporation and its consolidated subsidiaries, unless otherwise stated or indicated by context. We use the term "Encompass Health Corporation" to refer to Encompass Health Corporation alone wherever a distinction between Encompass Health Corporation and its subsidiaries is required or aids in the understanding of this filing. This proxy statement and the accompanying form of proxy are first being sent to our stockholders on April 2, 2024. ii ENCOMPASS HEALTH CORPORATION PROXY STATEMENT PROXY SUMMARY This summary highlights selected information about the items to be voted on at our annual meeting and information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider in deciding how to vote, so you should read the entire proxy statement carefully before voting. Proposals That Require Your Vote Proposals Board Recommendation Votes Required for Approval More Information 1. Election of 10 directors to serve until our 2025 annual meeting FOR each nominee Votes for the director exceed the votes against the director Page 8 2. Ratification of the appointment of our independent registered public accounting firm FOR Votes for the proposal exceed the votes against the proposal Page 15 3. Approval, on an advisory basis, of our executive compensation FOR Votes for the proposal exceed the votes against the proposal Page 17 4. Vote on a stockholder proposal requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts AGAINST Votes for represent the majority of our shares present and entitled to vote Page 18 Say-on-Pay

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing